The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Limited benefit from the addition of immunotherapy to chemotherapy in TKI-refractory EGFR-mutant lung adenocarcinoma.
 
Lingzhi Hong
No Relationships to Disclose
 
Whitney E Lewis
No Relationships to Disclose
 
Susan Varghese
No Relationships to Disclose
 
Melvin Rivera
No Relationships to Disclose
 
Robyn Du
No Relationships to Disclose
 
Pingjun Chen
No Relationships to Disclose
 
Haley Kemp
No Relationships to Disclose
 
Waree Rinsurongkawong
No Relationships to Disclose
 
Sadiq Rehmani
No Relationships to Disclose
 
Amy R. Spelman
No Relationships to Disclose
 
Yasir Y Elamin
Consulting or Advisory Role - AstraZeneca; Lilly; Sanofi; Takeda; Turning Point Therapeutics
Research Funding - AstraZeneca; Blueprint Medicines; Elevation Oncology; Forward; Lilly; Precision Therapeutics; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics; Xcovery
Travel, Accommodations, Expenses - Lilly
 
Marcelo Vailati Negrao
Consulting or Advisory Role - Merck; Mirati Therapeutics
Research Funding - Alaunos Therapeutics; AstraZeneca; Checkmate Pharmaceuticals; Genentech; Mirati Therapeutics; Novartis; Pfizer; ZIOPHARM Oncology
Other Relationship - Apothecom; Ashfield Healthcare; ZIOPHARM Oncology
 
Boris Sepesi
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex
Speakers' Bureau - AstraZeneca
 
Don Lynn Gibbons
Stock and Other Ownership Interests - Exact Sciences; Nektar
Consulting or Advisory Role - GlaxoSmithKline; Janssen Research & Development; Lilly; Menarini; Mitobridge; Napa Therapeutics; Ribon Therapeutics; Sanofi
Research Funding - AstraZeneca; Boehringer Ingelheim (Inst); Janssen Research & Development; Mirati Therapeutics (Inst); Mitobridge; NGM Biopharmaceuticals; Ribon Therapeutics; Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; BerGenBio; Takeda
 
J. Jack Lee
Honoraria - AstraZeneca; AstraZeneca
 
Jia Wu
No Relationships to Disclose
 
Natalie I Vokes
Honoraria - Sanofi
Consulting or Advisory Role - Sanofi/Regeneron
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; BrightPath Biotheraputics; Bristol-Myers Squibb; Catalyst Biotech; EMD Serono; Foundation medicine; Genentech/Roche; GlaxoSmithKline; Guardant Health; Hengrui Pharmaceutical; Janssen; Kairos Ventures; Leads Biolabs; Lilly; Mirati Therapeutics; Nexus Health Systems; Novartis; Pneuma Respiratory; Roche; Sanofi/Aventis; Spectrum Pharmaceuticals; Takeda
Research Funding - AstraZeneca (Inst); GlaxoSmithKline; Spectrum Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Licensing agreement between Spectrum and MD Anderson (including myself) regarding intellectual property for treatment of EGFR and HER2 exon 20 mutations
 
Jianjun Zhang
Honoraria - CancerNet; Geneplus; Geneplus; innovent biologics; Innovent Biologics; Innovent Biologics; Origimed; Roche; Sino-USA Biomedical Platform; Zhejiang Cancer Hospital; Zhejiang Cancer Hospital
Consulting or Advisory Role - AstraZeneca; AstraZeneca; AstraZeneca; Capital Medical University; Geneplus; Johnson & Johnson/Janssen; Novartis
Research Funding - Merck; Novartis
Travel, Accommodations, Expenses - innovent biologics; Zhejiang Cancer Hospital
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Lilly; EMD Serono; Lilly; Spectrum Pharmaceuticals
Research Funding - Boehringer Ingelheim (Inst); Lilly (Inst)